philanthropy

The award will go toward the development of MicrobeDx's technology for detecting the presence of bacteria in clinical urine specimens and to which antibiotics they are susceptible.

The university has renamed its genomics center, specializing in the gut microbiome, the Edison Family Center for Genome Sciences and Systems Biology.

The funds will be used to develop personalized treatments through collaborations within the Boston community, speed up clinical trials, and remove data bottlenecks.

The Harris Center for Precision Wellness will leverage emerging technologies in genomics, digital health, and data science. 

The gift is from a group of more than 20 philanthropists and will be used to develop a rapid diagnostic test for drug-resistant TB. 

The gift from the Hersch Foundation also will be used to create the Julie K. Hersch Chair in depression research and clinical care. 

With funding from CurePSP, the collaborators will investigate the genetic causes of the disease, which affects a patients' speech, mobility, balance, and other abilities.

Parlaying expertise in genetics, pathology, radiology, immunology, and gastroenterology, the center will focus on personalized medicine for Crohn's disease.

Under a pilot run, CytoVale, a developer of technologies for high-throughput single-cell analysis, has received funding and been assigned a mentor from BD.

Among the uses of the funding, UW will conduct exome sequencing to determine a patient's risk for developing the disease. 

Pages

An Australian-led team has generated a draft genome assembly of the invasive cane toad in hopes it will help in population control, the Sydney Morning Herald reports.

The New York Times reports that the US Department of Defense has implemented about half the recommendations made to improve safe handling of dangerous agents.

In PLOS this week: approach for teasing out archaic introgression in human genomes, immune transcription features in HCV infection, and more.

Stat News reports that Maryland is promoting itself to the biotech industry with a mobile billboard.